Influenza virus and coronavirus epidemics or pandemics have occurred in succession
worldwide throughout the early 21st century. These epidemics or pandemics pose a major …

Please cite this paper as: McKimm‐Breschkin (2012) Influenza neuraminidase inhibitors:
Antiviral action and mechanisms of resistance. Influenza and Other Respiratory Viruses 7 …

These clinical practice guidelines are an update of the guidelines published by the
Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza …

Los trabajadores del sector Salud requieren implementos especiales idóneos para
protegerse en su medio laboral; en los momentos actuales, estos requerimientos adquieren …

This report updates previous recommendations by CDC's Advisory Committee on
Immunization Practices (ACIP) regarding the use of antiviral agents for the prevention and …

Highlights•Approval of first endonuclease inhibitor for influenza treatment.•Represents a
new class of influenza drug.•Single dose is clinically effective.For the first time in nearly 20 …

In March and early April 2009 a new swine-origin influenza virus (S-OIV), A (H1N1),
emerged in Mexico and the USA. The virus quickly spread worldwide through human-to …

In addition to immunization programs, antiviral agents can play a major role for the control of
seasonal influenza epidemics and may also provide prophylactic and therapeutic benefits …

Fundamento La comunicación interna dentro de una organización garantiza que los
trabajadores realicen sus actividades de manera eficaz; lo cual, en el contexto salud, se …

Effective antivirals provide crucial benefits during the early phase of an influenza pandemic,
when vaccines are still being developed and manufactured. Currently, two classes of viral …